Abbott (NYSE: ABT) today announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction system pacing (CSP) ...
Avoiding the deluge of data created by the deployment of too many sensors requires a more considered approach to sensor selection and integration. Ideally, sensors should deliver just enough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results